Eckert & Ziegler SE (LON:0NZY)
London · Delayed Price · Currency is GBP · Price in EUR 14.77
-0.42 (-2.76%)
At close: Feb 11, 2026
Eckert & Ziegler SE Market Cap
Eckert & Ziegler SE has a market cap or net worth of 795.85 million as of February 12, 2026. Its market cap has decreased by -15.30% in one year.
Market Cap
795.85M
Enterprise Value
732.25M
Revenue
265.76M
Ranking
n/a
PE Ratio
22.94
Stock Price
14.77
Market Cap Chart
Since December 6, 1999, Eckert & Ziegler SE's market cap has increased from 100.88M to 795.85M, an increase of 688.91%. That is a compound annual growth rate of 8.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 805.36M | -3.40% |
| Dec 30, 2025 | 833.70M | 8.39% |
| Dec 30, 2024 | 769.13M | 3.11% |
| Dec 29, 2023 | 745.90M | -12.72% |
| Dec 30, 2022 | 854.62M | -47.84% |
| Dec 30, 2021 | 1.64B | 96.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 1.00B |
| CVS Group | 977.97M |
| Spire Healthcare Group | 814.80M |